{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:51:24Z","timestamp":1791273084608,"version":"4.1.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To provide the most recent literature on our understanding behind the pathogenesis and the treatment of calcinosis in dermatomyositis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Early diagnosis and controlling the overall disease activity are cornerstones to prevent calcinosis in juvenile dermatomyositis. Observational cohort studies showed that prolonged state of inflammation and features of vascular dysfunction like digital ulcers and abnormal nailfold capillaries are associated with calcinosis. Neutrophil activation and mitochondrial dysfunction have recently emerged as potential mechanistic pathways involved in calcinosis pathogenesis. Few recent case series have alluded to the efficacy of topical and intralesional sodium thiosulfate, while JAK inhibitors appear to be newer promising therapy in juvenile dermatomyositis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Calcinosis in dermatomyositis consists of deposition of insoluble calcium compounds in the skin and other tissues. It is prevalent in up to 75% of patients with juvenile dermatomyositis and up to 20% in adult dermatomyositis. While it leads to significant patient morbidity, we do not yet understand the pathogenesis in its entirety. Surgical excision although palliative is the mainstay of treatment and should be offered to patients. All available treatment options are only based on very low level of evidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001036","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:00:17Z","timestamp":1723215617000},"page":"453-458","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Calcinosis in dermatomyositis"],"prefix":"10.1097","volume":"36","author":[{"given":"Srijana","family":"Davuluri","sequence":"first","affiliation":[{"name":"Stanford School of Medicine Division of Rheumatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[{"name":"Stanford School of Medicine & Palo Alto VA Healthcare System, Division of Immunology & Rheumatology, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lood","sequence":"additional","affiliation":[{"name":"University of Washington, Division of Rheumatology, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"433","DOI":"10.55563\/clinexprheumatol\/94btoy","article-title":"Myositis-specific autoantibodies and their associated phenotypes in juvenile dermatomyositis: data from a German cohort","volume":"40","author":"Horn","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s10067-023-06751-0","article-title":"Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population","volume":"42","author":"Manwatkar","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"(Suppl 2)","key":"R3-20250526","article-title":"Features of myositis-specific and myositis-associated antibodies and antinuclear antibody patterns in patients with juvenile dermatomyositis","volume":"20","author":"Sener","year":"2022","journal-title":"Pediatr Rheumatol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"867","DOI":"10.35755\/jmedassocthai.2023.09.13890","article-title":"Characteristics and outcomes of juvenile dermatomyositis (JDM) in Thai children: experience from a tertiary referral center","volume":"106","author":"Sitthi","year":"2023","journal-title":"J Med Assoc Thailand"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"e003901","DOI":"10.1136\/rmdopen-2023-003901","article-title":"Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody","volume":"10","author":"Fu","year":"2024","journal-title":"RMD Open"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/rheumatology\/keab518","article-title":"Antinuclear matrix protein 2 antibody-positive idiopathic inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash","volume":"61","author":"Yuki","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"R7-20250526","article-title":"Calcinosis cutis and calciphylaxis in autoimmune connective tissue diseases","volume":"11","author":"Mormile","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"450","DOI":"10.55563\/clinexprheumatol\/h0s7tq","article-title":"A juvenile dermatomyositis: demographics, characteristics and disease outcome in an Egyptian cohort","volume":"40","author":"El-Garf","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12969-023-00904-w","article-title":"Juvenile dermatomyositis in Afro-Caribbean children: a cohort study in the French West Indies","volume":"21","author":"Felix","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"E195","DOI":"10.1097\/RHU.0000000000001696","article-title":"Clinical characteristics of juvenile idiopathic inflammatory myopathy and comparison with adult patients analysis from a multicentric cohort in Spain","volume":"28","author":"Loarce-Martos","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"R11-20250526","first-page":"S226","article-title":"Juvenile dermatomyositis: clinical characteristics, myositis specific antibody profile and disease course in a tertiary care centre in south India","volume":"18","author":"Tennelli","year":"2023","journal-title":"Indian J Rheumatol"},{"key":"R12-20250526","first-page":"298","article-title":"Initial manifestations and risk factors for calcinosis in juvenile dermatomyositis: a retrospective multicenter study","volume":"10","author":"Cakan","year":"2023","journal-title":"North Clin Istanb"},{"key":"R13-20250526","first-page":"1675","article-title":"Clinical and serological features of dermatomyositis in Tunisia","volume":"82","author":"Baya Chatti","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/23971983211053245","article-title":"Subcutaneous calcinosis: is it different between systemic sclerosis and dermatomyositis?","volume":"7","author":"Valenzuela","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"R15-20250526","first-page":"hcae045","article-title":"Diffuse subcutaneous calcinosis in dermatomyositis","author":"Liu","year":"2024","journal-title":"QJM"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/rheumatology\/kead256","article-title":"Development of a computed tomography calcium scoring technique for assessing calcinosis distribution, pattern and burden in dermatomyositis","volume":"63","author":"Cervantes","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/annrheumdis-2023-eular.255","article-title":"Dermatomyositis burden of disease manifestations and QOL impact: patient reported survey results","volume":"82","author":"Christopher Stine","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2022-eular.448","article-title":"Healthcare resource utilization and cost burden of dermatomyositis","volume":"81","author":"Bensimon","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R19-20250526","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-023-05377-4","article-title":"Long-standing and poorly controlled disease in juvenile dermatomyositis is associated with calcinosis: a real-world experience from a low-middle income country","author":"Mehta","year":"2023","journal-title":"Rheumatol Int"},{"key":"R20-20250526","first-page":"484","article-title":"The association of delay in diagnosis of juvenile dermatomyositis with various and clinical and laboratory parameters: experience of a centre in north india","volume":"41","author":"Tyagi","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.semarthrit.2020.06.007","article-title":"Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis","volume":"50","author":"Valenzuela","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R22-20250526","first-page":"1250","article-title":"Early abnormal nailfold capillary changes are predictive of calcinosis development in juvenile dermatomyositis","volume":"49","author":"Nozawa","year":"2022","journal-title":"J Rheumatol"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2023.09.076","article-title":"Prevalence of calcinosis cutis in the United States using the All of Us research database","volume":"90","author":"Kam","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"R24-20250526","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-023-05385-4","article-title":"Risk factors for developing calcinosis in juvenile dermatomyositis: subcutaneous and myofascial edema in initial magnetic resonance imaging","author":"Yi","year":"2023","journal-title":"Rheumatol Int"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/j.jid.2023.03.1331","article-title":"1316 Increased muscle involvement and younger age are distinctive features in dermatomyositis patients with skin of color","volume":"143","author":"Lee","year":"2023","journal-title":"J Invest Dermatol"},{"key":"R26-20250526","first-page":"S220","article-title":"Catching up with calcinosis: analysis of clinical characteristics, myositis specific antibodies and response to therapy in juvenile dermatomyositis in a cohort from a tertiary care centre in north India","volume":"18","author":"Aggarwal","year":"2023","journal-title":"Indian J Rheumatol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/injr.injr_139_22","article-title":"Clinical characteristics, therapeutics, and treatment outcomes of adult patients with antimelanoma differentiation-associated gene 5 dermatomyositis: a single-center experience from South India","volume":"18","author":"Padiyar","year":"2023","journal-title":"Indian J Rheumatol"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"810785","DOI":"10.3389\/fped.2021.810785","article-title":"Is anti-NXP2 autoantibody a risk factor for calcinosis and poor outcome in juvenile dermatomyositis patients? Case series","volume":"9","author":"Toplak","year":"2022","journal-title":"Front Pediatr"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.41078","article-title":"Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis","volume":"72","author":"Duvvuri","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"103061","DOI":"10.1016\/j.jaut.2023.103061","article-title":"Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis","volume":"138","author":"Duvvuri","year":"2023","journal-title":"J Autoimmun"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"102630","DOI":"10.1016\/j.jaut.2021.102630","article-title":"Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis","volume":"119","author":"Duvvuri","year":"2021","journal-title":"J Autoimmun"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"2218077","DOI":"10.1080\/21505594.2023.2218077","article-title":"Mitochondrial N-formyl methionine peptides contribute to exaggerated neutrophil activation in patients with COVID-19","volume":"14","author":"Kuley","year":"2023","journal-title":"Virulence"},{"key":"R33-20250526","article-title":"Mitochondrial ROS as a regulator of calcinosis in juvenile dermatomyositis","author":"Duvvuri","year":"2020","journal-title":"American College of Rheumatology Convergence"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1097\/RHU.0000000000001772","article-title":"Low-density granulocytes and neutrophil extracellular traps as biomarkers of disease activity in adult inflammatory myopathies","volume":"28","author":"Torres-Ruiz","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"109274","DOI":"10.1016\/j.clim.2023.109274","article-title":"Neutrophil extracellular trap formation in antineutrophil cytoplasmic antibody-associated and large-vessel vasculitis","volume":"249","author":"Michailidou","year":"2023","journal-title":"Clin Immunol"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"101768","DOI":"10.1016\/j.berh.2022.101768","article-title":"Calcinosis in dermatomyositis: origins and possible therapeutic avenues","volume":"36","author":"Davuluri","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.tips.2023.06.007","article-title":"NET-targeted therapy: effects, limitations, and potential strategies to enhance treatment efficacy","volume":"44","author":"Bonilha","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"R38-20250526","article-title":"The emerging role of Growth Differentiation Factor 15 as a potential disease biomarker in juvenile dermatomyositis","author":"Duvvuri","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3233\/JND-230168","article-title":"Contribution of complement, microangiopathy and inflammation in idiopathic inflammatory myopathies","volume":"11","author":"Honda","year":"2024","journal-title":"J Neuromuscul Dis"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"e210008","DOI":"10.20900\/immunometab20210008","article-title":"Mitochondrial calcification","volume":"3","author":"Duvvuri","year":"2021","journal-title":"Immunometabolism"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard-2022-223469","article-title":"Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis","volume":"82","author":"Wilkinson","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41584-022-00834-z","article-title":"The role of mitochondria in rheumatic diseases","volume":"18","author":"Becker","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"R44-20250526","first-page":"1438","article-title":"Lower HDL-associated apolipoprotein A-I levels associate with presence of calcinosis in adult dermatomyositis","volume":"73","author":"Bae","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"152276","DOI":"10.1016\/j.semarthrit.2023.152276","article-title":"Evolution and impact of a dedicated ultrasound clinic on clinical rheumatology practice at an academic medical center","volume":"63","author":"Fairchild","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R46-20250526","first-page":"325","article-title":"Intra-rater validation of calcinosis durometer measurements in juvenile and adult dermatomyositis","volume":"74","author":"Nelson","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R47-20250526","first-page":"S615","article-title":"I\u2019m well, but i\u2019m not: a case report of recurrent calcinosis cutis in a patient with well controlled juvenile dermatomyositis","volume":"38","author":"Akinfenwa","year":"2023","journal-title":"J Gen Intern Med"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1007\/s10067-020-05523-4","article-title":"Clinical and ultrasound response to intralesional sodium thiosulfate for the treatment of calcinosis cutis in the setting of systemic sclerosis. A case-based review","volume":"40","author":"L\u00f3pez-Sundh","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jdin.2020.07.002","article-title":"Efficacy of intralesional sodium thiosulfate for the treatment of dystrophic calcinosis cutis: a double-blind, placebo-controlled pilot study","volume":"1","author":"Winter","year":"2020","journal-title":"JAAD Int"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s40477-022-00665-4","article-title":"Clinical and ultrasonography follow-up of five cases of calcinosis cutis successfully treated with intralesional sodium thiosulfate","volume":"25","author":"Tubau","year":"2022","journal-title":"J Ultrasound"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12969-023-00941-5","article-title":"Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial","volume":"22","author":"Shiari","year":"2024","journal-title":"Pediatr Rheumatol Online J"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00198-022-06501-z","article-title":"Regression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling","volume":"33","author":"Motlaghzadeh","year":"2022","journal-title":"Osteoporos Int"},{"key":"R53-20250526","doi-asserted-by":"crossref","first-page":"152306","DOI":"10.1016\/j.semarthrit.2023.152306","article-title":"Effectiveness of topical sodium thiosulfate for ectopic calcifications and ossifications. Results of the CATSS-O study","volume":"63","author":"Gauffenic","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"318","DOI":"10.25251\/skin.6.4.8","article-title":"Calcinosis cutis: case report of topical sodium thiosulfate (STS) treatment in the context of dermatomyositis","volume":"6","author":"Haddadin","year":"2022","journal-title":"Skin"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/14397595.2014.988197","article-title":"Bisphosphonates in juvenile dermatomyositis with dystrophic calcinosis","volume":"25","author":"Tayfur","year":"2015","journal-title":"Mod Rheumatol"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"e252814","DOI":"10.1136\/bcr-2022-252814","article-title":"Bisphosphonate therapy for juvenile dermatomyositis-associated calcinosis and metaphyseal zebra lines","volume":"15","author":"Janarthanan","year":"2022","journal-title":"BMJ Case Rep"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-023-03170-z","article-title":"Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multicentral study in China","volume":"25","author":"Zhang","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"R58-20250526","first-page":"538","article-title":"Analysis of the clinical characteristics and therapeutic effect of refractory juvenile dermatomyositis to tofacitinib","volume":"61","author":"Zhou","year":"2023","journal-title":"Chin J Pediatr"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1093\/rheumatology\/keab421","article-title":"Calcinosis in refractory dermatomyositis improves with tofacitinib monotherapy: a case series","volume":"60","author":"Shneyderman","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"105532","DOI":"10.1016\/j.jbspin.2023.105532","article-title":"Contribution of the Interferon score in the management of an anti-NXP2 dermatomyositis patient with calcinosis successfully treated with tofacitinib","volume":"90","author":"Robert","year":"2023","journal-title":"Joint Bone Spine"},{"key":"R61-20250526","first-page":"402","article-title":"Efficacy of Janus kinase inhibitor baricitinib in the treatment of refractory juvenile dermatomyositis complicated by calcinosis","volume":"41","author":"Mastrolia","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R62-20250526","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13075-020-02164-5","article-title":"Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients","volume":"22","author":"Campanilho-Marques","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R63-20250526","first-page":"18","article-title":"Treatment response and outcomes of 63 cases of juvenile dermatomyositis-associated calcinosis","volume":"75","author":"Yi","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R64-20250526","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006629","article-title":"Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin","author":"Shahani","year":"2012","journal-title":"BMJ Case Rep"},{"key":"R65-20250526","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jbspin.2012.07.001","article-title":"Calcinosis universalis complicating juvenile dermatomyositis: improvement after intravenous immunoglobulin therapy","volume":"80","author":"Touimy","year":"2013","journal-title":"Joint Bone Spine"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:18:44Z","timestamp":1748294324000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001036","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]}}}